---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-005793"
form_type: "8-K"
ticker: "SABS"
cik: "0001833214"
company_name: "SAB Biotherapeutics, Inc."
filed_at: "2024-01-19T23:59:59+00:00"
generated_at: "2026-06-06T21:26:28.253358+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# SAB Biotherapeutics posts updated corporate presentation; no material news in filing

## Summary
- Filing announces availability of an updated corporate presentation on company website.
- No financial results, guidance changes, or specific operational updates disclosed in the 8-K.
- Presentation is furnished under Regulation FD and not incorporated by reference.
- Tickers SABS and SABSW trade on Nasdaq; no news affecting them directly.

## SEC filing metadata
- accession: 0000950170-24-005793
- form_type: 8-K
- ticker: SABS
- cik: 0001833214
- company_name: SAB Biotherapeutics, Inc.
- filed_at: 2024-01-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1833214/000095017024005793/0000950170-24-005793-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1833214/000095017024005793/sabs-20240119.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-005793
- JSON: https://secwatch.observer/filing/0000950170-24-005793.json
- Plain text: https://secwatch.observer/filing/0000950170-24-005793.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.